Data published in Scientific Reports confirms a low-burden visual evoked potential (VEP) assessment can be employed across multiple clinical trial sites as an…
VANCOUVER, BC, Jan. 6, 2026 /PRNewswire/ — Wondershare Technology, a leading creativity software company, recently announced the release of Wondershare FamiSafe…
LQT-23 is a potent, highly differentiated, first-in-class allosteric small molecule inhibitor of MSH3/MutSβ Unique mechanism of action with potential to…